EHRA 2021: Subcutaneous ICDs maintain cardioversion efficacy of 98% across five-year study

Press/Media: Research › Popular

Period	30-Apr-2021

Media contributions

Title	EHRA 2021: Subcutaneous ICDs maintain cardioversion efficacy of 98% across five-year study
Degree of recognition	International
Media name/outlet	Cardiac Rhythm News
Media type	Web
Date	30/04/2021
URL	https://cardiacrhythmnews.com/subcutaneous-icds-cardioversion-efficacy-five-year-study/
Persons	Isabelle van Gelder